John Cuellar, MD
Obstetrics & Gynecology · Arden, NCNPI 1639134422
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $11,415 of the $14,969 with a category attached, or 76.3%. 26 manufacturers reported payments, led by Organon at 47.1% of the total. Reporting peaked in 2019 at $5,366 and has fallen 97.8% since, to $120 in 2024. Among obstetrics & gynecology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $141.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$7K
- Merck$5K
- Covidien LP$715
- AbbVie$570
- Coloplast$352
- Coopersurgical, Inc.$183
- plus $1K from 20 others
What the payments were for
- Speaking & faculty fees$11,41576%
- Travel & lodging$1,0627%
- Food & beverage$2,48617%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 8 | $7,056 |
| Merck | 11 | $4,725 |
| Covidien LP | 7 | $715 |
| AbbVie | 24 | $570 |
| Coloplast | 8 | $352 |
| Coopersurgical, Inc. | 4 | $183 |
| Therapeuticsmd, Inc. | 6 | $171 |
| Healthtronics Stone Solutions, LLC | 4 | $154 |
| Pfizer | 8 | $138 |
| Novo Nordisk | 1 | $125 |
| Stryker | 1 | $120 |
| Intuitive Surgical | 1 | $117 |
| Astellas Pharma US Inc | 6 | $94 |
| Myriad Women's Health, Inc. | 1 | $92 |
| Smith+Nephew | 3 | $52 |
| Myovant Sciences Inc. | 2 | $52 |
| Minerva Surgical, Inc | 1 | $50 |
| Conmed Corporation | 1 | $42 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Axonics, Inc. | 1 | $26 |
| Mayne Pharma Commercial LLC | 1 | $25 |
| Osiris Therapeutics Inc. | 1 | $21 |
| Dermira, Inc. | 1 | $18 |
| Urovant Sciences Inc | 1 | $13 |
| Boston Scientific | 1 | $12 |
| Mission Pharmacal Company | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$11,527
- LigaSure$573
- Wegovy$125
- ALTIS$122
- VARIAX$120
- GAMMA$120
- Da Vinci Surgical System$117
- BIJUVA$116
- Uterine Manipulators & Injectors$100
How this compares
$14,969 in reported general payments places this provider in the 95th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 15 | $279 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Arden
- Jeffrey GarrisArden$11K
- Jerry MatkinsCharlotte$481K
- Laura McKainWilmington$475K
- Leslie Hansen-LindnerCharlotte$372K
- Robin MatthewsClyde$217K
- Haywood BrownDurham$165K
- Jack IngeRaleigh$157K
- Geeta SwamyDurham$142K
- Karie LafleurAsheville$135K
- Ty RobinsonHigh Point$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.